Healthy pregnancy hub

Citalopram (Celexa®) | Escitalopram (Cipralex®)

Last Update: 14 Nov 2024

Welcome to our fact sheet on Citalopram (Celexa®) and Escitalopram (Cipralex®) during pregnancy and breastfeeding. The information given is based on recent research and may change as science progresses. Remember that this content does not replace personalized advice from your healthcare team.

Introduction

Citalopram (Celexa®) and Escitalopram (Cipralex®) are antidepressants known as selective serotonin reuptake inhibitors (SSRIs), meaning they work on the neurotransmitter tooltip serotonin. They are used, among other things, to treat anxiety disorders.

The HEALTHY PREGNANCY HUB team is collaborating with MotherToBaby to share information on this topic.

Serene, our chatbot, can also answer your questions about medications during pregnancy.

Please note that this fact sheet is based on United States information. There may be minor differences in Canada. Always consult your healthcare professional for information tailored to your situation.

URL copied!

Disclaimer

HEALTHY PREGNANCY HUB provides a source of information validated by health professionals; however, this information is provided for informational purposes only and should not replace professional advice. Medical standards and practices evolve as new data becomes available, so it is imperative to consult your doctor or a qualified health professional for any questions or concerns regarding your health without delay or omission. It is the responsibility of your treating physician or any other health professional, based on their independent experience and knowledge of the patient, to determine the best way to evaluate and treat you.

HEALTHY PREGNANCY HUB does not specifically recommend or endorse any test, practitioner, treatment, product, or opinion mentioned on our platform. HEALTHY PREGNANCY HUB also does not replace the individual patient assessment based on the examination by the healthcare provider of each patient and the consideration of laboratory data and other patient-specific factors.

The use of the information available on our site is at your own risk. No person involved in the creation, production, promotion, or marketing of HEALTHY PREGNANCY HUB guarantees or represents, expressly or implicitly, anything regarding the information available on the platform, which is provided “as it is”. All warranties are expressly excluded and disclaimed, including but not limited to implied warranties of merchantability or fitness for a particular purpose, as well as any warranties arising by law or otherwise in law or from trade or usage. Any statements or representations made by any other person or entity are void.

While consulting symptoms or other medical information on our platform may guide your discussions with your healthcare professional, this information should not be used to make a medical diagnosis or determine treatment. Before making changes to your supplement or medication regimen, please discuss with your medical team or contact 811 (Canada) to ensure the relevance of these changes to your individual situation.

Credits
MotherToBaby
Organization of Teratology Information Specialists (OTIS)
View source
Émy Roberge
Centre hospitalier universitaire Sainte-Justine

Associated Fact Sheets

Would you like to know more about this topic? Explore our associated Fact Sheets.

Associated Resources

In this section, you can browse, in one place, through our various documents and tools for pregnant people, their families and healthcare professionals. You'll find vidéos, downloadable brochures, podcast episodes, and more!

Partners

Your pregnancy during COVID-19
uOttawa
University of Calgary
University of British Columbia
University of Toronto
University of Saskatchewan
University of Manitoba
University of Alberta
Unity Health
Unité de soutien SSA
UDEM
Stratos
SOGC
SickKids
RQRM
QTNPR
QPC
PWHR
Public Health Agency of Canada
PregMed France
SPOR
MPrint
Mitacs
Médicaments Grossesse
McGill
Médicament Québec
FRQ
Perinatal Network
CIHR
IQVIA
iPOP
Institut national de santé publique du Québec
INRS
Innovative Medicines Canada
IN-uTERO
Immerscience
Groww
Enrich
Design Develop Discover
Dalla Lana
CUSM
CIHR
CHU Sainte-Justine
Centre of Excellence on Partnership with Patients and the Public
CAN-AIM
Canadian Pharmacogenomics Network for Drug Safetry
CAMCCO
CAMCCO-L
C4T
BORN Ontario
Black Physicians of Canada
BC Children's Hospital
Association of Faculties of Pharmacy of Canada
Alberta Health Services
MICYRN
UQAT
Dalhousie University